Superworth

CapsoVision EPS CV

Diluted earnings per share by quarter and over the last twelve months, from 2024.

Last 12 months, to Jun 30, 2026
−$0.63
Latest quarter, Q2 FY26
−$0.15
Fiscal year 2025
−$4.84

CapsoVision's earnings per share was −$0.63 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.15.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$4.84n/a
FY2024−$9.83n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.15n/a−$0.63
Q1 FY26−$0.15n/a−$2.50
Q4 FY25−$0.16n/a−$4.84
Q3 FY25−$0.17n/a−$6.89
Q2 FY25−$2.02n/a−$9.51
Q1 FY25−$2.49n/a−$10.07
Q4 FY24−$2.21n/a−$9.83
Q3 FY24−$2.79n/an/a
Q2 FY24−$2.58n/an/a
Q1 FY24−$2.25n/an/a

Against its peers

Companies in Medical - Devices nearest CapsoVision's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CVCapsoVision−$0.63
ELMDElectromed$1.31+56% a year
CNMDCONMED$1.85−48% a year
TMDXTransMedics$3.84+99% a year
Peer median$1.85

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on CapsoVision

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.